Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

General Electric Companys (GE) manufacturing facility in Rochester, New York, which focuses on the assembly of electronic boards, is expected to be closed, while its operations – relocated in China.

General Electric shares closed higher for the fourth time in the past six trading sessions on Wednesday. The stock went up 0.59% ($0.15) to $25.71, with the intraday high and the intraday low being at $25.72 and $25.46 respectively. In the week ended on August 6th the shares of the industrial giant added 0.98% to their market value compared to a week ago, which marked the second gain in the past seven weeks, but yet, the smallest one since the week ended on June 11th. The stock has neutralized earlier losses and is now up 0.39% so far during the current month, following a 5.18% slump in July. The latter has been a fifth consecutive month of losses. For the entire past year, General Electric shares gained 1.44%.

The company did not disclose an exact number of employees working at the facility.

However, as reported by Seeking Alpha, citing GE officials, the decision is to affect less than 100 employees.

According to CNN Money, the 15 analysts, offering 12-month forecasts regarding General Electric’s stock price, have a median target of $28.00, with a high estimate of $33.00 and a low estimate of $22.00. The median estimate is an 8.91% surge compared to the closing price of $25.71 on August 9th.

The same media also reported that 8 out of 19 surveyed investment analysts had rated General Electric’s stock as “Hold”, and 8 – as “Buy”. On the other hand, 2 analysts had recommended selling the stock.

Daily and Weekly Pivot Levels

With the help of the Camarilla calculation method, todays levels of importance for the General Electric stock are presented as follows:

R1 – $25.73
R2 – $25.76
R3 (Range Resistance – Sell) – $25.78
R4 (Long Breakout) – $25.85
R5 (Breakout Target 1) – $25.94
R6 (Breakout Target 2) – $25.97

S1 – $25.69
S2 – $25.66
S3 (Range Support – Buy) – $25.64
S4 (Short Breakout) – $25.57
S5 (Breakout Target 1) – $25.48
S6 (Breakout Target 2) – $25.45

By using the traditional method of calculation, the weekly levels of importance for General Electric Company (GE) are presented as follows:

Central Pivot Point – $25.65
R1 – $25.98
R2 – $26.17
R3 – $26.50
R4 – $26.82

S1 – $25.46
S2 – $25.13
S3 – $24.94
S4 – $24.74

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • GBP/JPY edges lower as slowing UK wage growth adds to BoE pause caseGBP/JPY edges lower as slowing UK wage growth adds to BoE pause case Having rebounded from a two-month low, the GBP/JPY currency pair edged lower on Tuesday, after data showed UK wage growth had decelerated further in the three months to October, while adding to the case of a rate pause by the Bank of […]
  • GBP/SEK off 1-week low with focus on cenbank meetingsGBP/SEK off 1-week low with focus on cenbank meetings The GBP/SEK currency pair gained on Wednesday, while rebounding from a one-week low, as investors awaited the outcome of the Bank of England’s and Riksbank's policy meetings this week.The Bank of England is expected to maintain its […]
  • AUD/USD extended gains from yesterdayAUD/USD extended gains from yesterday Australian dollar continued to advance against its US peer on Tuesday after the Australian elections and another set of upbeat Chinese data.AUD/USD touched a session high at 0.9288 at 5:31 GMT, the pairs highest point since July. Support […]
  • Merck & Co Inc. share price down, reports a fall in sales and lowers outlook for the yearMerck & Co Inc. share price down, reports a fall in sales and lowers outlook for the year Merck & Co Inc. stated a fall in third-quarter revenues and narrowed its projection for full-year performance. Meanwhile, the company said that its new cancer medicine won a breakthrough therapy designation from the FDA.The […]
  • Palantir Relies on U.S. Contracts as CEO Defends PlatformPalantir Relies on U.S. Contracts as CEO Defends Platform Key Moments: U.S. government revenue jumped 66% in the fourth quarter to $570 million, lifting total sales to $1.41 billion. Meanwhile, Palantir forecast 2026 revenue of $7.18 billion to $7.20 billion, more than 60% above 2025 […]
  • Forex Market: EUR/GBP daily trading forecastForex Market: EUR/GBP daily trading forecast Yesterday’s trade saw EUR/GBP within the range of 0.7553-0.7677. The pair closed at 0.7570, losing 1.26% on a daily basis.At 7:37 GMT today EUR/GBP was down 0.11% for the day to trade at 0.7562. The pair touched a daily low at 0.7552 at […]